• Publications
  • Influence
A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes
Background The comparative effects of statins, ezetimibe with or without statins and proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors remain unassessed. Design Bayesian networkExpand
  • 24
  • 1
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century
Male breast cancer (MBC) is a rare disease for which there is limited understanding of treatment patterns and prognostic factors.
  • 14
  • 1
Disease Milestones through Bibliometric Analysis of the Top 100 Cited Articles in Multiple Myeloma
Multiple myeloma (MM) accounts for 1.6% of all cancers and 5%-10% of all hematologic malignancies in the United States (US). Despite marked progress in disease management, it remains incurable withExpand
  • 2
  • 1
  • PDF
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
We retrospectively reviewed all patients (n = 243) receiving bortezomib, lenalidomide, and dexamethasone (VRd) induction followed by autologous stem cell transplantation (ASCT) for multiple myelomaExpand
  • 6
Venous thromboembolism risk with contemporary lenalidomide‐based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta‐analysis
Thromboprophylaxis is routinely used with lenalidomide‐based regimens in multiple myeloma because of a substantial risk of venous thromboembolism (VTE). However, little is known about the incidenceExpand
  • 4
Role of one, two and three doses of high-dose chemotherapy with autologous transplantation in the treatment of high-risk or relapsed testicular cancer: a systematic review
Approximately 20–30% of patients with metastatic germ cell cancers (GCCs) can develop relapsed or refractory (RR) disease, about 40–50% of patients who relapse after salvage chemotherapy may reachExpand
  • 3
Reply to On the proportion of male breast cancer among all breast cancers
The first 2 authors contributed equally to this article.In a recent issue of Cancer, Yadav et al explore the treatment patterns and prognostic factors of male breast cancer (MBC) in the UnitedExpand